Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity

Neurobiology of Aging

Volumn 34, Issue 9, 2013, Pages 2158-2163

  de Waal, Hanneke ^a   Stam, Cornelis J ^b   de Haan, Willem ^a   van Straaten, Elisabeth C W ^b   Blankenstein, Marinus A ^b   Scheltens, Philip ^a   van der Flier, Wiesje M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; APOE genotype; Quantitative analysis; Resting state EEG

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; APOLIPOPROTEIN E4 GENE; ARTICLE; BETA RHYTHM; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; OSCILLATION; PARIETO-OCCIPITAL SULCUS; PRIORITY JOURNAL; RESTING STATE NETWORK; SYNAPTOGENESIS; THETA RHYTHM; TISSUE DISTRIBUTION;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; ELECTROENCEPHALOGRAPHY; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OCCIPITAL LOBE; PARIETAL LOBE; SEVERITY OF ILLNESS INDEX;

EID: 84878928641     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.03.007     Document Type: Article

References (37)

1. Babiloni C., Benussi L., Binetti G., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., Ferri R., Frisoni G., Ghidoni R., Miniussi C., Rodriguez G., Romani G.L., Squitti R., Ventriglia M.C., Rossini P.M. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study. Ann. Neurol. 2006, 59:323-334.
2. Bales K.R. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology 2010, 59:295-302.
3. Bennys K., Rondouin G., Vergnes C., Touchon J. Diagnostic value of quantitative EEG in Alzheimer's disease. Neurophysiol. Clin. 2001, 31:153-160.
4. Brown J.A., Terashima K.H., Burggren A.C., Ercoli L.M., Miller K.J., Small G.W., Bookheimer S.Y. Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc. Natl. Acad. Sci. U.S.A 2011, 108:20760-20765.
5. Dauwels J., Vialatte F., Cichocki A. Diagnosis of Alzheimer's disease from EEG signals: where are we standing?. Curr. Alzheimer Res. 2010, 7:487-505.
6. de Haan W., Stam C.J., Jones B.F., Zuiderwijk I.M., van Dijk B.W., Scheltens P. Resting-state oscillatory brain dynamics in Alzheimer disease. J.Clin. Neurophysiol. 2008, 25:187-193.
7. de Waal H., Stam C.J., Blankenstein M.A., Pijnenburg Y.A., Scheltens P., van der Flier W.M. EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity. J.Neurol. Neurosurg. Psychiatry 2010, 82:67-71.
8. de Waal H., Stam C.J., de Haan W., van Straaten E.C., Scheltens P., van der Flier W.M. Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics. Neurobiol. Aging 2011, 33:1008.e25-1008.e31.
9. Gasser T., Bächer P., Möcks J. Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr. Clin. Neurophysiol. 1982, 53:119-124.
10. Hashimoto M., Yasuda M., Tanimukai S., Matsui M., Hirono N., Kazui H., Mori E. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001, 57:1461-1466.
11. Hauser P.S., Narayanaswami V., Ryan R.O. Apolipoprotein E: from lipid transport to neurobiology. Prog. Lipid Res. 2011, 50:62-74.
12. Jelic V., Julin P., Shigeta M., Nordberg A., Lannfelt L., Winblad B., Wahlund L.O. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J.Neurol. Neurosurg. Psychiatry 1997, 63:59-65.
13. Jeong J. EEG dynamics in patients with Alzheimer's disease. Clin. Neurophysiol. 2004, 115:1490-1505.
14. Jiang L., Yin X., Yin C., Zhou S., Dan W., Sun X. Different quantitative EEG alterations induced by TBI among patients with different APOE genotypes. Neurosci Lett. 2011, 505:160-164.
15. Kramer G., van der Flier W.M., de Langen C., Blankenstein M.A., Scheltens P., Stam C.J. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls. Clin. Neurophysiol. 2008, 119:2727-2732.
16. Lehtovirta M., Partanen J., Könönen M., Soininen H., Helisalmi S., Mannermaa A., Ryynänen M., Hartikainen P., Riekkinen P. Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurobiol. Aging 1996, 17:523-526.
17. Liedorp M., van der Flier W.M., Hoogervorst E.L., Scheltens P., Stam C.J. Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohort. Dement. Geriatr. Cogn. Disord. 2009, 27:18-23.
18. Machulda M.M., Jones D.T., Vemuri P., McDade E., Avula R., Przybelski S., Boeve B.F., Knopman D.S., Petersen R.C., Jack C.R. Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch. Neurol. 2011, 68:1131-1136.
19. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
20. Olde Dubbelink K.T., Stoffers D., Deijen J.B., Twisk J.W., Stam C.J., Berendse H.W. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol. Aging 2013, 34:408-418.
21. Ossenkoppele R., van der Flier W.M., Zwan M.D., Adriaanse S.F., Boellaard R., Windhorst A.D., Barkhof F., Lammertsma A.A., Scheltens P., van Berckel B.N. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 2013, 80:359-365.
22. Ponomareva N.V., Korovaitseva G.I., Rogaev E.I. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol. Aging 2008, 29:819-827.
23. Pucci E., Belardinelli N., Cacchiò G., Signorino M., Angeleri F. EEG power spectrum differences in early and late onset forms of Alzheimer's disease. Clin. Neurophysiol. 1999, 110:621-631.
24. Royall D.R., Palmer R.F., Petrovitch H., Ross G.W., Masaki K., White L.R. Modeling regional vulnerability to Alzheimer pathology. Neurobiol. Aging 2012, 33:1556-1563.
25. Schreiter-Gasser U., Gasser T., Ziegler P. Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr. Clin. Neurophysiol. 1994, 90:267-272.
26. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
27. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., Van Broeckhoven C., van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 1998, 55:964-968.
28. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A 1995, 92:4725-4727.
29. Trachtenberg A.J., Filippini N., Ebmeier K.P., Smith S.M., Karpe F., Mackay C.E. The effects of APOE on the functional architecture of the resting brain. Neuroimage 2012, 59:565-572.
30. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
31. van Beijsterveldt C.E., van Baal G.C. Twin and family studies of the human electroencephalogram: a review and a meta-analysis. Biol. Psychol. 2002, 61:111-138.
32. van der Flier W.M., Pijnenburg Y.A., Fox N.C., Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOEε4 allele. Lancet Neurol. 2011, 10:280-288.
33. van der Flier W.M., Schoonenboom S.N., Pijnenburg Y.A., Fox N.C., Scheltens P. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 2006, 67:526-527.
34. van der Vlies A.E., Koedam E.L., Pijnenburg Y.A., Twisk J.W., Scheltens P., van der Flier W.M. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. Psychol. Med. 2009, 39:1907-1911.
35. van der Vlies A.E., Pijnenburg Y.A., Koene T., Klein M., Kok A., Scheltens P., van der Flier W.M. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. Dement. Geriatr. Cogn. Disord. 2007, 24:98-103.
36. Whitham E.M., Lewis T., Pope K.J., Fitzgibbon S.P., Clark C.R., Loveless S., DeLosAngeles D., Wallace A.K., Broberg M., Willoughby J.O. Thinking activates EMG in scalp electrical recordings. Clin. Neurophysiol. 2008, 119:1166-1175.
37. Whitham E.M., Pope K.J., Fitzgibbon S.P., Lewis T., Clark C.R., Loveless S., Broberg M., Wallace A., DeLosAngeles D., Lillie P., Hardy A., Fronsko R., Pulbrook A., Willoughby J.O. Scalp electrical recording during paralysis: quantitative evidence that EEG frequencies above 20 Hz are contaminated by EMG. Clin. Neurophysiol. 2007, 118:1877-1888.